Valuation check: GBCMY's profit margin is 19.98%, above the sector sector average of 13.78%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Global Bio-chem Technology Group Company Limited (GBCMY) currently reports a profit margin of 19.98% as of June 2026. That compares with 137.02% in the prior-year period — down 85.4% year over year. That is above the sector sector average of 13.78%. Use the charts on this page to explore Global Bio-chem Technology Group Company Limited's profit margin history and peer comparisons.
Global Bio-chem Technology Group Company Limited's profit margin decreased from 137.02% to 19.98% — a 85.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Global Bio-chem Technology Group Company Limited's profit margin of 19.98% is higher than the its sector sector average of 13.78%. That is roughly 45.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Global Bio-chem Technology Group Company Limited's current 19.98% should be judged against industry norms (sector average: 13.78%) and against GBCMY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 19.98%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.78%. From there, open related valuation or income-statement pages for Global Bio-chem Technology Group Company Limited, and consider following GBCMY for alerts when major investors trade the stock.